Cargando…

Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo

Vaccines that can rapidly induce strong and robust antibody-mediated immunity could improve protection from certain infectious diseases for which current vaccine formulations are inefficient. For indications such as anthrax and influenza, antibody production in vivo is a correlate of efficacy. Toll-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weir, Genevieve M., Karkada, Mohan, Hoskin, David, Stanford, Marianne M., MacDonald, Lisa, Mansour, Marc, Liwski, Robert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491120/ https://www.ncbi.nlm.nih.gov/pubmed/28662082 http://dx.doi.org/10.1371/journal.pone.0180073

Ejemplares similares

Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple models
por: Weir, Genevieve, et al.
Publicado: (2014)

Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam(1)CSK(4) and Pam(3)CSK(4)
por: Megy, Simon, et al.
Publicado: (2020)

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response
por: Weir, Genevieve M, et al.
Publicado: (2014)

Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck
por: Zhang, Aiguo, et al.
Publicado: (2022)

An efficient and scalable synthesis of potent TLR2 agonistic PAM(2)CSK(4)
por: Kaur, Arshpreet, et al.
Publicado: (2018)

Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice
por: Huang, Lu, et al.
Publicado: (2015)

A20 Is Critical for the Induction of Pam3CSK4-Tolerance in Monocytic THP-1 Cells
por: Hu, Jinyue, et al.
Publicado: (2014)

Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4
por: Chen, Yi-Guo, et al.
Publicado: (2016)

The Synthetic Bacterial Lipopeptide Pam3CSK4 Modulates Respiratory Syncytial Virus Infection Independent of TLR Activation
por: Nguyen, D. Tien, et al.
Publicado: (2010)

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
por: Weir, Genevieve M., et al.
Publicado: (2011)

Adjuvant Pam3CSk4 does not improve the immunization against Cryptococcus gattii infection in C57BL/6 mice
por: de Campos, Gabriela Yamazaki, et al.
Publicado: (2023)

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients
por: Berinstein, Neil L, et al.
Publicado: (2012)

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
por: Qiao, Yidan, et al.
Publicado: (2022)

The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs
por: Martínez-Orellana, Pamela, et al.
Publicado: (2017)

Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus
por: Li, Tiantian, et al.
Publicado: (2020)

Regulation, targets and functions of CSK
por: Zhu, Shudong, et al.
Publicado: (2023)

The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models
por: Halliday, Alice, et al.
Publicado: (2016)

Differential Effects of the Toll-Like Receptor 2 Agonists, PGN and Pam3CSK4 on Anti-IgE Induced Human Mast Cell Activation
por: Yu, Yangyang, et al.
Publicado: (2014)

Regulation of the Src Family Kinases by Csk
por: Okada, Masato
Publicado: (2012)

CSK-mediated signalling by integrins in cancer
por: Maldonado, Horacio, et al.
Publicado: (2023)

Editorial: Regulation and dysfunction of CSK and CHK
por: Zhu, Shudong, et al.
Publicado: (2023)

Pro-inflammatory response ensured by LPS and Pam3CSK4 in RAW 264.7 cells did not improve a fungistatic effect on Cryptococcus gattii infection
por: de Campos, Gabriela Yamazaki, et al.
Publicado: (2020)

Mitotic Activation of c‐Src Is Suppressed by Csk
por: Ohsato, Yoshiharu, et al.
Publicado: (1994)

Apoptosis regulation by the tyrosine-protein kinase CSK
por: Fortner, Andra, et al.
Publicado: (2022)

TLR2 Ligand Pam3CSK4 Regulates MMP-2/9 Expression by MAPK/NF-κB Signaling Pathways in Primary Brain Microvascular Endothelial Cells
por: Zhu, Hongyan, et al.
Publicado: (2018)

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform
por: MacDonald, Lisa D., et al.
Publicado: (2017)

The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton’s Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions
por: Parra-Izquierdo, Iván, et al.
Publicado: (2021)

Gene Silencing and Haploinsufficiency of Csk Increase Blood Pressure
por: Lee, Hyeon-Ju, et al.
Publicado: (2016)

Siegesbeckia pubescens Makino inhibits Pam(3)CSK(4)-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation
por: Sang, Wei, et al.
Publicado: (2018)

Toll-like Receptor 1/2 Agonist Pam3CSK4 Suppresses Lipopolysaccharide-driven IgG1 Production while Enhancing IgG2a Production by B Cells
por: Lee, Sang-Hoon, et al.
Publicado: (2018)

LYP inhibits T cell activation when dissociated from CSK
por: Vang, Torkel, et al.
Publicado: (2012)

Small molecule inhibition of Csk alters affinity recognition by T cells
por: Manz, Boryana N, et al.
Publicado: (2015)

SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function
por: Cui, Nan, et al.
Publicado: (2019)

Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
por: Berinstein, Neil L, et al.
Publicado: (2015)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C
por: Aznar, M. Angela, et al.
Publicado: (2019)

The Tyrosine Kinase Csk Dimerizes through Its SH3 Domain
por: Levinson, Nicholas M., et al.
Publicado: (2009)

Regulation of Src and Csk Nonreceptor Tyrosine Kinases in the Filasterean Ministeria vibrans
por: Schultheiss, Kira P., et al.
Publicado: (2014)

Prime-boost with Chikungunya virus E2 envelope protein combined with Poly (I:C) induces specific humoral and cellular immune responses
por: Amaral, Marcelo Pires, et al.
Publicado: (2021)

The LEPSIS Pam-File
por: DELPHI Collaboration
Publicado: (1982)

Exploiting poly(I:C) to induce cancer cell apoptosis
por: Bianchi, Francesca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_flnlsv0aga8akcl0l37fufo0bs